文献速递妇科

血液类固醇水平预测子宫内膜癌生存并反映肿瘤雌激素信号

Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling.
PubMed 文献 · Gynecol Oncol · 2019-12-06

该研究在100例子宫内膜癌患者中采用液相色谱-串联质谱法检测七种类固醇激素,并与临床特征、腹部脂肪分布及原发肿瘤基因表达进行关联分析。结果显示,低水平的17OH-孕酮、11-脱氧皮质醇和雄烯二酮与侵袭性肿瘤特征及较差疾病特异性生存相关;校正术前组织学风险后,低17OH-孕酮和低11-脱氧皮质醇仍独立预测不良预后。高类固醇水平则与雌激素信号及炎症相关基因上调相关。

要点

  • 低17OH-孕酮、11-脱氧皮质醇和雄烯二酮与侵袭性肿瘤特征及较差生存相关。
  • 校正组织学类型和分级后,低17OH-孕酮和低11-脱氧皮质醇独立预测不良预后。
  • 高类固醇水平与雌激素信号及炎症相关基因上调相关,低水平则与有丝分裂和细胞周期基因表达增加相关。

核心结论

  • 某些内源性类固醇低水平与侵袭性肿瘤特征和较差生存相关,可能提供独立于现有组织学标志物的术前信息。

研究设计与样本

  • 前瞻性队列研究,纳入100例子宫内膜癌患者,用液相色谱-串联质谱法量化七种类固醇激素,并从腹部CT评估脂肪分布,比较激素水平与临床特征、脂肪分布及原发肿瘤基因表达。

主要发现

  • 低17OH-孕酮、11-脱氧皮质醇和雄烯二酮与侵袭性肿瘤特征和较差疾病特异性生存相关(分别为p = .003、p = .001和p = .02)。
  • 校正基于组织学类型和分级的术前风险后,低17OH-孕酮和低11-脱氧皮质醇独立预测不良结局,风险比分别为2.69(p = .033,95%CI:1.09-6.68)和3.40(p = .020,1.21-9.51)。
  • 低类固醇水平患者的肿瘤显示有丝分裂和细胞周期进展相关基因表达增加,而高类固醇水平与雌激素信号及炎症相关基因上调相关。
  • 雌酮和雌二醇与腹部脂肪体积(总、内脏、皮下)相关(所有p < .001),但与内脏脂肪比例无关。
  • 循环雌激素水平较高的患者雌激素信号相关基因表达增加。

关键数值与推荐

  • 低17OH-孕酮预测不良结局的HR为2.69(p = .033,95%CI:1.09-6.68)。
  • 低11-脱氧皮质醇预测不良结局的HR为3.40(p = .020,95%CI:1.21-9.51)。

临床怎么用

  • 某些内源性类固醇低水平可能提供术前预后信息,独立于现有组织学标志物。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Blood-based biomarkers are attractive due to ease of sampling and standardized measurement technology, reducing obstacles to clinical implementation. The objective of this study was to evaluate a clinically available method of steroid hormone measurement for its prognostic potential in endometrial cancer. METHODS: We quantified seven steroid hormones by liquid chromatography-tandem mass spectrometry in 100 endometrial cancer patients from a prospective cohort. Abdominal fat distribution was assessed from abdominal computed tomography (CT) scans. Steroid hormone levels were compared to clinical characteristics, fat distribution and gene expression in primary tumor samples. RESULTS: Low levels of 17OH-progesterone, 11-deoxycortisol and androstenedione were associated with aggressive tumor characteristics and poor disease specific survival (p = .003, p = .001 and p = .02 respectively). Adjusting for preoperative risk based on histological type and grade, low 17OH-progesterone and 11-deoxycortisol independently predicted poor outcome with hazard ratios of 2.69 (p = .033, 95%CI: 1.09-6.68) and 3.40 (p = .020, 1.21-9.51), respectively. Tumors from patients with low steroid level displayed increased expression of genes related to mitosis and cell cycle progression, whereas high steroid level was associated with upregulated estrogen signaling and genes associated with inflammation. Estrone and estradiol correlated to abdominal fat volume in all compartments (total, visceral, subcutaneous, p < .001 for all), but not to the visceral fat proportion. Patients with higher levels of circulating estrogens had increased expression of estrogen signaling related genes. CONCLUSION: Low levels of certain endogenous steroids are associated with aggressive tumor traits and poor survival and may provide preoperative information independent of histological biomarkers already in use.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Forsse D, Tangen IL, Fasmer KE, et al. Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. Gynecol Oncol. 2019. PMID: 31813586. doi:10.1016/j.ygyno.2019.11.123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。